However, in the setting of AKI, guanabenz improved outcome in both Nox4 KO and WT mice, suggesting that protective eIF2α/ATF4 signaling can be further boosted during AKI in normal mice with competent Nox4 regulation. The gene discussed is ATF4; the disease is acute kidney injury.